Lotus Bio-Technology Development Corp.
LBTD
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.06M
Close$
Share Statistics
| Market cap | $8.06 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 1.91 |
| Outstanding Shares | 334,405,434 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -50 |
|---|---|
| PEG | 51.79 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Lotus Bio-Technology Development Corp.
0
CEO: Hoyt Christopher Lotus Bio-Technology Development Corp. (LBTD) operates as a biotechnology firm, primarily dedicated to the processing of organic substances and the creation of natural consumer products for the Chinese market. This entity, which began it...